Navigation Links
Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry
Date:5/9/2008

Hospital-wide conversion achieves technology and sensor standardization,

creates process efficiencies and reduces costs

IRVINE, Calif., May 9 /PRNewswire-FirstCall/ -- Saint Barnabas Medical Center and Masimo, the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse Oximetry, have announced the completion of Saint Barnabas Medical Center's hospital-wide implementation of Masimo SET pulse oximetry. The New Jersey-based hospital performed an extensive comparison and thorough evaluation spanning virtually every department and cited superior performance, technology capabilities and future clinical application as chief reasons for converting to Masimo SET.

"The decision to convert to Masimo SET pulse oximetry was multifaceted, with numerous benefits that we didn't think were possible in one technology," said Shyan Sun, M.D., Director of Neonatology, Saint Barnabas Medical Center. "With Masimo, we now have a standardized technology for oximetry that not only enables sensor consistency and standardization across departments at reduced costs, but also provides the system compatibility necessary to track oximetry inventory and costs -- all in a technology platform that is uniquely expandable to support our current and future oximetry needs."

Saint Barnabas Medical Center is the flagship of the Saint Barnabas Health Care System, New Jersey's largest integrated health care delivery system, and ranks among the top 5 percent of all hospitals in the country. The 601-bed institution treats more patients annually and delivers more babies than any other facility in New Jersey, including more than 40,000 inpatients admissions, over 65,000 Emergency Department visits, and nearly 7,000 births each year. Additionally, the Medical Center and its Ambulatory Care Center provide treatment and services for more than 300,000 outpatient visits annually. The Saint Barnabas Health Care System includes six acute care hospitals
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Saint Vincent Health System of Erie, Pennsylvania Named One of AARP 2007 Best Employers for Workers Over 50
2. ASTAR Air Cargo, The Church of Jesus Christ of Latter-day Saints and DHL to Help Peruvian Earthquake Victims
3. Saint Barnabas Health Care System Expands Business Relationship with Thomson Healthcare
4. Saint Marys Reno RNs Choose CNA/NNOC in Landslide 64 Percent Vote for 500 RNs
5. Revise guidelines for weight gain during pregnancy, says Saint Louis U. obstetrician
6. Providence Saint Joseph Medical Named LA Countys Third Primary Stroke Center
7. MSU engineering team designs innovative medical device
8. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
10. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
11. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)...to Serve as Senior Technology Advisor, SALT LAKE ...f Directors,of Sonic Innovations, Inc. (Nasdaq: S...ing aids, today announced that Andrew Raguskus has...us will continue as a member of the,Board of Direc...s a result,of Mr. Raguskus, announcement, the Boar...
(Date:5/13/2008)...NASDAQ: CRME TSX: COM, VANCOUVER, May 13 /PRNewsw...ME / TSX: COM) today reported financial results fo... unless specified otherwise, are,expressed in Cana...ally,Accepted Accounting Principles (Canadian GAAP...hange rate was CAD$1.00=US$0.9742., Results of Op...
(Date:5/13/2008)...itals that treat the poor from improving, study fi... -- The quality of care at hospitals that treat po...et hospitals, is lagging well behind hospitals tha..., These hospitals, which rely on state and fede...t have the money to improve the quality of care at...
(Date:5/13/2008)...y research could slow to a crawl unless regulators...researchers assert in an upcoming opinion piece. ,...fety research. It just isnt the right fit, says Na... at the Johns Hopkins Berman Institute of Bioethic...lished in the June issue of The Joint Commission J...
Breaking Medicine News(10 mins):Health News:Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 2Health News:Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 3Health News:Cardiome Reports First Quarter Results 2Health News:Cardiome Reports First Quarter Results 3Health News:Cardiome Reports First Quarter Results 4Health News:Cardiome Reports First Quarter Results 5Health News:Quality Lags at Safety-Net Hospitals 2Health News:Quality Lags at Safety-Net Hospitals 3Health News:Treating safety research like other clinical studies slows progress 2Health News:Treating safety research like other clinical studies slows progress 3
...t the caffeine content of beverages such as tea, c...u can now clear your suspicion about the decaf lab...e home based kit, produced by researchers at Washi...a dipstick analysis. The results of the present st...
...shop of Canterbury, has warned that National Healt...stem could compromise the quality and centrality o...the Church of England suggested that "short-term e...ervice delivery, and this could put vulnerable peo...
...o enter into partnership with real estate agents t... new homes. // The vicar will offer his services ...ers are intended to cover almost every eventuality...ar in Eccles, Greater Manchester is the pioneer be...
...private medical college described the Budhia’s med... of Government doctors who had examined the buddin... long distances. According to the report of the go...e kid’s clinical parameters such as serum urea, se...
Other Medicine News:Health News:Caffeine Content In Beverages To Be Identified By Home Test Kit 2Health News:Head Of The Church Of England Asks NHS To Respect Patient Needs 2Health News:New Home New Blessings 2
(Date:5/13/2008)...XIENCE V in SPIRIT III Trial Experience Better, Lo...rombosis than Patients T...wswire-FirstCall/ -- Long-term data,presented for ...bott,s U.S.,pivotal trial studying the XIENCE(TM) ...trated that XIENCE V continues to deliver clinical...
(Date:5/13/2008)...ce, May 13 /- NicOx S.A.,(E...c. has initiated the,first in a series of planned ... patients, under the companies, collaborative agre...ertensive agents using NicOx,proprietary technolo...rom,the companies, joint research program, of whic...
(Date:5/12/2008)...ucts Expand Infection Prevention Business, DUBLIN...Health, a,global provider of products and services...h care, today announced it has completed the,acqui...the manufacturer of,infection prevention products ...rep(R) brand products are used widely in U.S. hosp...
(Date:5/12/2008)...wswire-USNewswire/ -- The Alliance for Lupus,Resea...resolution,supporting the goals and ideals of Nati...other,s Day. The resolution, introduced by Senator...lls on all Americans to take the,week of May 11th ... on,women,s health issues, and recognizes the impo...
Breaking Medicine Technology:XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 2NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 3Cardinal Health Completes Enturia Acquisition 2Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues 2ETH Zurich researchers develop antibody test 2378 1ETH Zurich researchers develop antibody test 2378 2Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 3660 1Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 3660 2Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 3660 3Covance to Present at Raymond James 29th Annual Institutional Investors Conference 13260 1AT4 wireless and Ekahau Partner to Deploy Combined Asset and Staff Tracking Solution for Hospitals 13258 1AT4 wireless and Ekahau Partner to Deploy Combined Asset and Staff Tracking Solution for Hospitals 13258 2
... HOUSTON, March 20, 2007 - An overexpressed prote...ng forced to devour,themselves, removing one of th...ell growth, researchers at The University of Texas...issue of Molecular,Cancer Research. , The protein ...,TG2, previously has been found by researchers at ...
...Phase 2 Clinical Trials Initiated, CRANBURY, N.J.,...s, a biopharmaceutical company developing small,mo...ones for the,treatment of a range of human genetic...sitive results from its recently completed,Phase 1...rate,AT2101) for Gaucher disease at the of Medica...
Other Medicine Technology:Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 2Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 3Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease 2Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine
For the qualitative detection of single and multiple drugs and drug metabolites in human urine
For the qualitative detection of single and multiple drugs and drug metabolites in human urine
For the qualitative differential detection of circulating Plasmodium falciparum (P.f) antigen and an antigen that is common to all four species of malaria:plasmodium falciparum (P.f), plasmodium viv
Medicine Products: